Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats

Mediators of Inflammation

Volumn 13, Issue 1, 2004, Pages 13-19

  Borrego, Aluet ^a   Zamora, Zullyt B ^a   González, Ricardo ^a   Romay, Cheyla ^a   Menéndez, Silvia ^a   Hernández, Frank ^a   Montero, Teresita ^b   Rojas, Enys ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

^b 'Dr Luis Diaz Soto' Surg Clin H   (Cuba)

Author keywords

Antioxidant defenses; Cisplatin induced nephrotoxicity; Lipid peroxidation; Ozone oxidative preconditioning

Indexed keywords

ANTIOXIDANT; CATALASE; CISPLATIN; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; OZONE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY EXAMINATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CATALASE; CISPLATIN; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; KIDNEY; KIDNEY DISEASES; MALE; OXIDOREDUCTASES; OZONE; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA;

EID: 2442487906     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350410001664806     Document Type: Article

References (35)

1. Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998; 34: 1522-1534.
2. Winston JA, Safirstein R. Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol 1985; 249: F490-F496.
3. Dobyan DC, Levi J, Jacobs C. Mechanism of cis-platinum nephrotoxicity II. Morphological observations. J Pharmacol ExpTher 1980; 213: 551-556.
4. Brady HR, Kone BC, Stromski ME. Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am J Physiol 1990; 258: F1181-F1187.
5. Baliga R, Ueda N, Walker PD. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 1997; 29: 465-477.
6. Matsushima H, Yonemura K, Ohishi K, Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 1998; 131: 518-526.
7. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med 2000; 109: 665-678.
8. Lau AH. Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int 1999; 56: 1295-1298.
9. Zhang JG, Lindup WE. Cisplatin nephrotoxicity: decreases in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices. Biochem Pharmacol 1994; 47: 1127-1135.
10. Hussain KC, Morris C, Whitworth GL. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem 1998; 178: 127-133.
11. Appenroth D, Frob S, Kersten L, Splinter FK, Winnefeld K. Protective effect of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol 1997; 71: 677-683.
12. Somani SM, Husain K, Whitworth C, Rybak LP. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol 2000; 86: 234-240.
13. Babu E, Gopal Krishman V, Sriganth IN. Cisplatin induced nephrotoxicity and the modulating effect of glutathione esters. Mol Cell Biochem 1995; 144: 7-11.
14. 2 production in cispaltin-induced nephrotoxicity. Biochem Biophys Res Commun 1998; 242: 310-312.
15. Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 2001; 12: 2683-2690.
16. Sheikh-Hamad D, Timmins K, Jalali Z. Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment. J Am Soc Nephrol 1997; 8: 1640-1644.
17. Barber E, Menéndez S, León OS, et al. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischemia. Mediat Inflamm 1999; 8: 37-41.
18. Beutler F, Duron O, Mikus B. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 16: 882-889.
19. Minami M, Yoshikawa H. A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta 1979; 92: 337-372.
20. Rice Evans C, Diplock AT. Laboratory techniques in biochemistry and molecular biology. In: Burtin RH, Knippenberg PH, eds. Techniques in Free Radical Research, Amsterdam: Elsevier, 1991: 199-201.
21. Faraji B, Kang HK, Valentine JL. Methods for determining Glutathione peroxidase activity in blood. Clin Chem 1987; 33: 539-543.
22. Ohkawa H, Orishi N, Yagi K. Assay for lipid peroxidation in animals and tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 165-175.
24. Ikeda S, Fukuzaki A, Kaneto H, Ishidoya S, Orikasa S. Role of protein kinase C in cisplatin nephrotoxicity. Int J Urol 1999; 6: 245-250.
25. Blochl-Daum B, Pehamberger H, Kurz C, et al. Effects of cisplatin on urinary thromboxane B2 excretion. Clin Pharmacol Ther 1995; 58: 418-424.
26. Abdel-Gayoum AA, El-Jenjan KB, Ghwarsha KA. Hyperlipidemia in cisplatin-induced nephrotoxic rats. Hum Exp Toxicol 1999; 18: 454-459.
27. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990; 66: 913-931.
28. Neschis DG, Safford SD, Raghunath PN, et al. Thermal preconditioning before rat arterial balloon injury: limitation of injury and sustained reduction of intimal thickening. Thromb Vasc Biol 1998; 18: 120-126.
29. Riepe MW, Ludolph AC. Chemical preconditioning: a cytoprotective strategy. Mol Cell Biochem 1997; 174: 249-254.
30. León OS, Menéndez S, Merino N, et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediat Inflamm 1998; 7: 289-294.
31. Peralta C, León OS, Xaus C, et al. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res 1999; 31: 191-196.
32. Peralta C, Xaus C, Bartrons R, León OS, Gelpí E, Roselló-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radic Res 2000; 33: 595-605.
33. Hernández F, Menéndez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med 1995; 19: 115-119.
34. Marklund SL. Properties of extracellular superoxide dismutase from human lung. Biochem J 1984; 220: 269-272.
35. Whiteside C, Hassan HM. Induction and inactivation of catalase and superoxide dismutase of Escherichia coli by ozone. Arch Biochem Biophys 1987; 257: 464-471.